Evidence map›Paper›PMID 25667410›Full record

ArticleThe Journal of general physiology2015

Positions of the cytoplasmic end of BK α S0 helix relative to S1-S6 and of β1 TM1 and TM2 relative to S0-S6.

Guoxia Liu, Sergey I Zakharov, Yongneng Yao, Steven O Marx, Arthur Karlin

Abstract read
In one paragraph

Article in The Journal of general physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. CaTrends in biochemical sciences · 2017
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guoxia LiuDepartment of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Sergey I ZakharovDepartment of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Yongneng YaoDepartment of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Steven O MarxDepartment of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 sm460@columbia.edu ak12@columbia.edu.
Arthur KarlinDepartment of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 Department of Medicine, Division of Cardiology; Department of Pharmacology; and Department of Biochemistry, Department of Physiology, and Department of Neurology, Center for Molecular Recognition, College of Physicians and Surgeons, Columbia University, New York, NY 10032 sm460@columbia.edu ak12@columbia.edu.

Funding

BK CHANNEL MODULATION BY BETA SUBUNITSR01NS054946 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KARLIN, ARTHUR, MARX, STEVEN O · 2007 to 2014
$2.8M
NINDS NIH HHS R01 NS054946
6 · The paper itself

Abstract

The large-conductance, voltage- and Ca(2+)-gated K(+) (BK) channel consists of four α subunits, which form a voltage- and Ca(2+)-gated channel, and up to four modulatory β subunits. The β1 subunit is expressed in smooth muscle, where it slows BK channel kinetics and shifts the conductance-voltage (G-V) curve to the left at [Ca(2+)] > 2 µM. In addition to the six transmembrane (TM) helices, S1-S6, conserved in all voltage-dependent K(+) channels, BK α has a unique seventh TM helix, S0, which may contribute to the unusual rightward shift in the G-V curve of BK α in the absence of β1 and to a leftward shift in its presence. Such a role is supported by the close proximity of S0 to S3 and S4 in the voltage-sensing domain. Furthermore, on the extracellular side of the membrane, one of the two TM helices of β1, TM2, is adjacent to S0. We have now analyzed induced disulfide bond formation between substituted Cys residues on the cytoplasmic side of the membrane. There, in contrast, S0 is closest to the S2-S3 loop, from which position it is displaced on the addition of β1. The cytoplasmic ends of β1 TM1 and TM2 are adjacent and are located between the S2-S3 loop of one α subunit and S1 of a neighboring α subunit and are not adjacent to S0; i.e., S0 and TM2 have different trajectories through the membrane. In the absence of β1, 70% of disulfide bonding of W43C (S0) and L175C (S2-S3) has no effect on V50 for activation, implying that the cytoplasmic end of S0 and the S2-S3 loop move in concert, if at all, during activation. Otherwise, linking them together in one state would obstruct the transition to the other state, which would certainly change V50.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnimalsCysteineHEK293 CellsHumansIon Channel GatingLarge-Conductance Calcium-Activated Potassium ChannelsMiceMolecular Sequence DataProtein Structure, TertiaryCysteineLarge-Conductance Calcium-Activated Potassium Channels

Identifiers

PMID25667410
PMCPMC4338161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.